XRF — XRF Scientific Income Statement
0.000.00%
Last trade - 00:00
- AU$175.31m
- AU$172.49m
- AU$55.26m
- 99
- 44
- 84
- 86
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 29 | 29.1 | 31.3 | 40 | 55.3 |
Cost of Revenue | |||||
Gross Profit | 11.4 | 12.3 | 13.8 | 17.3 | 23 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 25.9 | 24.6 | 24.5 | 31.8 | 43.5 |
Operating Profit | 3.15 | 4.45 | 6.79 | 8.19 | 11.8 |
Net Income Before Taxes | 3.15 | 4.45 | 6.79 | 8.19 | 11.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.14 | 3.12 | 5.13 | 6.09 | 8.18 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.14 | 3.12 | 5.13 | 6.08 | 7.69 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.14 | 3.12 | 5.13 | 6.08 | 7.69 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.017 | 0.023 | 0.033 | 0.045 | 0.056 |
Dividends per Share |